Cytokinetics
South San Francisco · Founded 1998
About Cytokinetics
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
Company Facts
- Founded: 1998
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $2.4B
- Funding stage: IPO
- Last round: Post-IPO Debt (Sep 2025)
- Ticker: nasdaq:CYTK
- Website: cytokinetics.com
- Phone: 6506243010
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/cytokinetics-39479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.